Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfamethoxazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.97 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.97 |
| ▸ | MAPT | P10636 | 1/20 | 0.97 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.66 |
| ▸ | EDNRA | P25101 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | PPIA | P62937 | 3/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.57 |
| ▸ | EDNRB | P24530 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfamethoxazole SCHEMBL3656 | 0.98 | ALDH1A1 (1.00) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL6896861 | 0.98 | ALDH1A1 (1.00) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL28142856 | 0.97 | ALDH1A1 (0.97) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL28501919 | 0.97 | ALDH1A1 (0.97) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL22467841 | 0.97 | ALDH1A1 (0.97) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL5870744 | 0.97 | ALDH1A1 (0.97) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL28565481 | 0.97 | ALDH1A1 (0.97) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL29625775 | 0.97 | ALDH1A1 (0.97) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL4539943 | 0.95 | ALDH1A1 (0.94) | ALDH1A1ADRA1AMAPTTSHRMAPK1 | |
| Sulfamethoxazole SCHEMBL28003342 | 0.95 | ALDH1A1 (0.94) | ALDH1A1ADRA1AMAPTTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119050449-A | Sodium ion battery | 深圳市豪鹏科技股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-115624551-A | Trimethoprim solid dispersion and composite preparation and preparation method thereof | 江苏集萃新型药物制剂技术研究所有限公司 | 2023-01-20 | — | — | CN | claimed |
| CN-109160904-B | Preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-111521712-B | Liquid chromatography analysis method for simultaneously determining contents of 3 sulfonamides and 4 quinolones | 重庆方通动物药业有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-111521712-A | Liquid chromatography analysis method for simultaneously determining contents of 3 sulfonamides and 4 quinolones | 重庆方通动物药业有限公司 | 2020-08-11 | — | — | CN | claimed |
| CN-109160904-A | The preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2019-01-08 | — | — | CN | claimed |
| US-20180161438-A1 | Aqueous Ophthalmic Composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2018-06-14 | — | — | US | claimed |
| CN-107614018-A | Aqueous ophthalmic composition | 乐敦制药株式会社 | 2018-01-19 | — | — | CN | claimed |
| CN-107385560-A | Polyester doughnut and preparation method thereof with antibacterial, self-cleaning function | 武汉纺织大学 | 2017-11-24 | — | — | CN | claimed |
| CN-106265527-A | A kind of water soluble trimethoprim compositions and complex composition thereof | 江西派尼生物药业有限公司 | 2017-01-04 | — | — | CN | claimed |
| CN-105903019-A | Compound sulfanilamide soluble powder and preparation method thereof | 湖南泰谷生物兽药有限公司 | 2016-08-31 | — | — | CN | claimed |
| CN-103494828-A | Preparation method of sulfanilamide salt and trimethoprim soluble powder | RINGPU TIANJIN BIO TECHNOLOGY CO LTD | 2014-01-08 | — | — | CN | claimed |
| CN-101313977-B | Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | LEI QINGLIAN | 2010-12-15 | — | — | CN | claimed |
| CN-100463668-C | Reversibly hot gelified water soluble medicine composition | PEIXUE LING (CN) | 2009-02-25 | — | — | CN | claimed |
| CN-101313977-A | Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | LEI QINGLIAN (CN) | 2008-12-03 | — | — | CN | claimed |
| CN-101011402-A | Compound sulfadimidine sodium injection and its preparation method | TIANJIN SHENGJI GROUP CO LTD (CN) | 2007-08-08 | — | — | CN | claimed |
| CN-1706365-A | Reversibly hot gelified water soluble medicine composition | LING PEIXUE (CN) | 2005-12-14 | — | — | CN | claimed |
| CN-1048393-C | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 2000-01-19 | — | — | CN | claimed |
| CN-1097593-A | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 1995-01-25 | — | — | CN | claimed |
| JP-10295777-A | — | — | None | — | — | JP | disclosed |
| WO-2024262353-A1 | COMPOSITION FOR ORAL CAVITY | ライオン株式会社 | 2024-12-26 | — | — | WO | disclosed |
| CN-119050449-A | Sodium ion battery | 深圳市豪鹏科技股份有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118985596-A | Multifunctional diagnosis and treatment integrated nano polymer carrier and application thereof in preparation of citrus yellow dragon disease diagnosis and treatment agent | 西南大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118766840-A | Preparation process and formula of low-deuterium-water contact lens eye-wetting liquid | 上海善普生物科技有限公司 | 2024-10-15 | — | — | CN | disclosed |
| EP-3895693-B1 | HYDROGEL COMPOSITION AND HYDROGEL LENS | PEGAVISION CORP (TW) | 2024-10-09 | — | — | EP | disclosed |
| CN-113527581-B | Water gel composition and water gel lens | 晶硕光学股份有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-114558112-B | Ophthalmic preparation and preparation method and application thereof | 易舟(上海)生物医药有限公司 | 2024-07-26 | — | — | CN | disclosed |
| WO-2024135344-A1 | OPHTHALMIC PRODUCT | ライオン株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-12005070-B2 | Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder | TOYO SUGAR REFINING CO., LTD. (JP) | 2024-06-11 | — | — | US | disclosed |
| CN-114344253-B | Deuterium-depleted water contact lens eye-wetting liquid and preparation method thereof | 上海善普生物科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-111526892-B | Ophthalmic product and masking method | 狮王株式会社 | 2024-03-22 | — | — | CN | disclosed |
| WO-2023197675-A1 | BACTERICIDE FOR PREVENTING AND CONTROLLING CITRUS HUANGLONGBING AND USE THEREOF | 江西新龙生物科技股份有限公司 | 2023-10-19 | — | — | WO | disclosed |
| US-20230321058-A1 | Ophthalmic Composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| CN-116440156-A | Composition for inhibiting pollen rupture | 参天制药株式会社 | 2023-07-18 | — | — | CN | disclosed |
| CN-115624551-A | Trimethoprim solid dispersion and composite preparation and preparation method thereof | 江苏集萃新型药物制剂技术研究所有限公司 | 2023-01-20 | — | — | CN | disclosed |
| WO-2022260050-A1 | LIQUID PREPARATION OF BRIMONIDINE | アイ・セラピーズ・エル・エル・シー | 2022-12-15 | — | — | WO | disclosed |
| CN-115362022-A | Centrifugally-excited fluid systems, devices, and methods | ODX创新有限公司 | 2022-11-18 | — | — | CN | disclosed |
| CN-111948313-B | Method for determining content of trimethoprim and multiple sulfanilamide drugs in drug and application thereof | 贵州省兽药饲料检测所(贵州省兽药残留监测中心) | 2022-09-23 | — | — | CN | disclosed |
| CN-109160904-B | Preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-109160904-B | Preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-109160904-B | Preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114868761-A | Bactericide for preventing and treating citrus greening disease and application thereof | 江西新龙生物科技股份有限公司 | 2022-08-09 | — | — | CN | disclosed |
| JP-2022109891-A | STABILIZED EYE DROPS CONTAINING 4 COMPONENTS | キョーリンリメディオ株式会社 | 2022-07-28 | — | — | JP | disclosed |
| CN-112043820-B | Eye preparation and preparation method and application thereof | 易舟(上海)生物医药有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-20220168434-A1 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | Yizhou (Shanghai) Biological Medicine Co, Ltd. (CN) | 2022-06-02 | — | — | US | disclosed |
| CN-114558112-A | Eye preparation and preparation method and application thereof | 易舟(上海)生物医药有限公司 | 2022-05-31 | — | — | CN | disclosed |
| US-11331390-B2 | Ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2022-05-17 | — | — | US | disclosed |
| WO-2022097731-A1 | OPHTHALMIC LIQUID PREPARATION | アイ・セラピーズ・エル・エル・シー | 2022-05-12 | — | — | WO | disclosed |
| CN-111521712-B | Liquid chromatography analysis method for simultaneously determining contents of 3 sulfonamides and 4 quinolones | 重庆方通动物药业有限公司 | 2022-05-06 | — | — | CN | disclosed |
| EP-3988122-A1 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | Yizhou (Shanghai) Biological Medicine Co, Ltd. (CN) | 2022-04-27 | — | — | EP | disclosed |
| CN-114344253-A | Deuterium-depleted water contact lens eye-moistening liquid and preparation method thereof | 上海善普生物科技有限公司 | 2022-04-15 | — | — | CN | disclosed |
| WO-2022075472-A1 | LIQUID PREPARATION OF BRIMONIDINE | アイ・セラピーズ・エル・エル・シー | 2022-04-14 | — | — | WO | disclosed |
| EP-3895693-A1 | HYDROGEL COMPOSITION AND HYDROGEL LENS | Pegavision Corporation (TW) | 2021-10-20 | — | — | EP | disclosed |
| US-20210315807-A1 | HYDROGEL COMPOSITION AND HYDROGEL LENS | PEGAVISION CORPORATION (TW) | 2021-10-14 | — | — | US | disclosed |
| CN-109069421-B | Ophthalmic composition | 乐敦制药株式会社 | 2021-10-12 | — | — | CN | disclosed |
| WO-2021120937-A1 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | 童妍(上海)医疗器械有限公司 | 2021-06-24 | — | — | WO | disclosed |
| EP-3446682-B1 | OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2021-05-26 | — | — | EP | disclosed |
| CN-213148667-U | Stirring pot viscosity detection and material adding circuit for medicine production | 佛山市南海北沙制药有限公司 | 2021-05-07 | — | — | CN | disclosed |
| CN-110257188-B | Liquid for lens, contact lens, and method for producing same | JSR株式会社 | 2021-05-04 | — | — | CN | disclosed |
| US-10976473-B2 | Method for producing medical device and medical device | JSR CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| CN-107249652-B | Method for manufacturing medical device and medical device | JSR株式会社 | 2021-01-12 | — | — | CN | disclosed |
| CN-112043820-A | Eye preparation and preparation method and application thereof | 童妍(上海)医疗器械有限公司 | 2020-12-08 | — | — | CN | disclosed |
| US-10842875-B2 | Ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2020-11-24 | — | — | US | disclosed |
| CN-111886001-A | Eye drop type eye-washing medicinal composition | 参天制药株式会社 | 2020-11-03 | — | — | CN | disclosed |
| CN-111836627-A | Composition for suppressing pollen cracking | 参天制药株式会社 | 2020-10-27 | — | — | CN | disclosed |
| WO-2020184479-A1 | OPHTHALMIC COMPOSITION HAVING INHIBITED IRRITATING SENSATION | ロート製薬株式会社 | 2020-09-17 | — | — | WO | disclosed |
| CN-111526892-A | Ophthalmic product and masking method | 狮王株式会社 | 2020-08-11 | — | — | CN | disclosed |
| CN-111521712-A | Liquid chromatography analysis method for simultaneously determining contents of 3 sulfonamides and 4 quinolones | 重庆方通动物药业有限公司 | 2020-08-11 | — | — | CN | disclosed |
| WO-2020158894-A1 | COMPOSITION CONTAINING POLYSULFIDE COMPOUND | 協和発酵バイオ株式会社 | 2020-08-06 | — | — | WO | disclosed |
| EP-3329943-B1 | METHOD FOR PRODUCING MEDICAL DEVICE AND MEDICAL DEVICE | JSR CORP (JP) | 2020-07-08 | — | — | EP | disclosed |
| EP-2783689-B1 | KERATOCONJUNCTIVAL PROTECTING AGENT, OR KERATOCONJUNCTIVAL DISORDER INHIBITING AGENT | TOYO SUGAR REFINING CO LTD (JP) | 2019-09-25 | — | — | EP | disclosed |
| WO-2019176946-A1 | EYEDROP-TYPE EYEWASH COMPOSITION | 参天製薬株式会社 | 2019-09-19 | — | — | WO | disclosed |
| WO-2019176947-A1 | POLLEN BURSTING-INHIBITING COMPOSITION | 参天製薬株式会社 | 2019-09-19 | — | — | WO | disclosed |
| US-20190125877-A1 | Ophthalmic Composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2019-05-02 | — | — | US | disclosed |
| CN-109160904-A | The preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2019-01-08 | — | — | CN | disclosed |
| CN-109160904-A | The preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2019-01-08 | — | — | CN | disclosed |
| CN-109160904-A | The preparation method of sulfamethoxazole sodium | 寿光富康制药有限公司 | 2019-01-08 | — | — | CN | disclosed |
| CN-109069421-A | Ophthalmic composition | 乐敦制药株式会社 | 2018-12-21 | — | — | CN | disclosed |
| EP-3106458-B1 | MALEIC ACID SALT OF ANTI-PRION COMPOUND, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION OF THE SAME | UNIV GIFU (JP) | 2018-12-19 | — | — | EP | disclosed |
| US-20180289812-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2018-10-11 | — | — | US | disclosed |
| US-10039709-B2 | Bioadhesive compositions for epithelial drug delivery | TRILOGIC PHARMA LLC (US) | 2018-08-07 | — | — | US | disclosed |
| US-20180217294-A1 | METHOD FOR PRODUCING MEDICAL DEVICE AND MEDICAL DEVICE | JSR CORPORATION (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20180161438-A1 | Aqueous Ophthalmic Composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
| EP-3329943-A1 | METHOD FOR PRODUCING MEDICAL DEVICE AND MEDICAL DEVICE | JSR Corporation (JP) | 2018-06-06 | — | — | EP | disclosed |
| CN-104797241-B | aqueous ophthalmic composition | 乐敦制药株式会社 | 2018-03-27 | — | — | CN | disclosed |
| CN-107614018-A | Aqueous ophthalmic composition | 乐敦制药株式会社 | 2018-01-19 | — | — | CN | disclosed |
| CN-107385560-A | Polyester doughnut and preparation method thereof with antibacterial, self-cleaning function | 武汉纺织大学 | 2017-11-24 | — | — | CN | disclosed |
| US-9809563-B2 | Maleic acid salt of anti-prion compound, method for producing the same and pharmaceutical composition of the same | GIFU UNIVERSITY (JP) | 2017-11-07 | — | — | US | disclosed |
| CN-107260660-A | Aqueous ophthalmic composition | 乐敦制药株式会社 | 2017-10-20 | — | — | CN | disclosed |
| US-9724312-B2 | Agent for the prevention, improvement or treatment of retinal disease | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2017-08-08 | — | — | US | disclosed |
| US-20170105934-A1 | AQUEOUS OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2017-04-20 | — | — | US | disclosed |
| CN-104407206-B | A kind of pharmaceutical production detects warning circuit with agitated kettle | 佛山市南海北沙制药有限公司 | 2017-03-29 | — | — | CN | disclosed |
| US-20170056335-A1 | Ophthalmic Composition | RHOTO PHARMACEUTICAL CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
| CN-106265527-A | A kind of water soluble trimethoprim compositions and complex composition thereof | 江西派尼生物药业有限公司 | 2017-01-04 | — | — | CN | disclosed |
| US-20160368885-A1 | MALEATE OF ANTI-PRION COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION THEREOF | NOBELPHARMA CO., LTD. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-20160367584-A1 | PROTECTIVE AGENT FOR KERATOCONJUNCTIVA OR SUPPRESSIVE AGENT FOR KERATOCONJUNCTIVAL DISORDER | TOYO SUGAR REFINING CO., LTD. (JP) | 2016-12-22 | — | — | US | disclosed |
| EP-3106458-A1 | MALEATE OF ANTI-PRION COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION THEREOF | Gifu University (JP) | 2016-12-21 | — | — | EP | disclosed |
| CN-106163565-A | Ophthalmic composition | 乐敦制药株式会社 | 2016-11-23 | — | — | CN | disclosed |
| CN-105903019-A | Compound sulfanilamide soluble powder and preparation method thereof | 湖南泰谷生物兽药有限公司 | 2016-08-31 | — | — | CN | disclosed |
| US-9427473-B2 | Aqueous ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2016-08-30 | — | — | US | disclosed |
| US-20160243030-A1 | Aqueous Ophthalmic Composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| US-9345779-B2 | Aqueous ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2016-05-24 | — | — | US | disclosed |
| US-20160136275-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2016-05-19 | — | — | US | disclosed |
| US-9320802-B2 | Aqueous ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2016-04-26 | — | — | US | disclosed |
| US-20160089345-A1 | KIT OF OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2016-03-31 | — | — | US | disclosed |
| CN-103933198-B | A kind of active mineral ion profit eye liquid | SUI LIMEI (CN) | 2016-03-09 | — | — | CN | disclosed |
| CN-103764168-B | Aqueous ophthalmic composition | ROHTO PHARMACEUTICAL CO.,LTD. (JP) | 2016-02-17 | — | — | CN | disclosed |
| US-20160022669-A1 | SELF-SOLIDIFYING BARRIER IMPLANT AND METHOD OF MAKING THE IMPLANT | MELMAN STEVEN A (US) | 2016-01-28 | — | — | US | disclosed |
| CN-105055430-A | Novel formula preparation used for treating diarrhea of young livestock and application thereof | LIU CHENGWANG | 2015-11-18 | — | — | CN | disclosed |
| CN-103282052-B | Aqueous ophthalmic compositions | ROHTO PHARMACEUTICAL CO.,LTD. (JP) | 2015-08-12 | — | — | CN | disclosed |
| CN-103269686-B | Contact lens ophthalmic composition | ROHTO PHARMACEUTICAL CO.,LTD. (JP) | 2015-08-05 | — | — | CN | disclosed |
| US-20150209437-A1 | AQUEOUS OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2015-07-30 | — | — | US | disclosed |
| CN-104797241-A | Aqueous ophthalmic composition | ROHTO PHARMA | 2015-07-22 | — | — | CN | disclosed |
| US-20150165051-A1 | AQUEOUS OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2015-06-18 | — | — | US | disclosed |
| US-9050369-B2 | Aqueous ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2015-06-09 | — | — | US | disclosed |
| US-9034931-B2 | Aqueous ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2015-05-19 | — | — | US | disclosed |
| CN-204269723-U | Pharmaceutical production agitated kettle detection alarm circuit | NANHAI BEISHA PHARMACEUTICAL CO LTD | 2015-04-15 | — | — | CN | disclosed |
| CN-104491386-A | Compound Chinese herbal preparation for treating chicken infectious rhinitis | ZHENGZHOU HOUYI PHARMACEUTICAL | 2015-04-08 | — | — | CN | disclosed |
| CN-104435253-A | Eye drops containing active ions and preparation method of eye drops | QINGDAO HOUKE INFORMATION ENG CO LTD | 2015-03-25 | — | — | CN | disclosed |
| CN-104435128-A | Pure natural organic extract eye drops and preparation method thereof | QINGDAO HOUKE INFORMATION ENG CO LTD | 2015-03-25 | — | — | CN | disclosed |
| EP-1967186-B1 | COMPOSITION FOR SOFT CONTACT LENS AND ADSORPTION SUPPRESSING METHOD | LION CORP (JP) | 2015-03-11 | — | — | EP | disclosed |
| CN-104407206-A | Stirring pot detection alarm circuit for pharmaceutical production | NANHAI BEISHA PHARMACEUTICAL CO LTD | 2015-03-11 | — | — | CN | disclosed |
| US-20150064281-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2015-03-05 | — | — | US | disclosed |
| CN-104367674-A | Organic active lubricating eye drop and preparation method thereof | QINGDAO HOUKE INFORMATION ENG CO LTD | 2015-02-25 | — | — | CN | disclosed |
| US-20150025154-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2015-01-22 | — | — | US | disclosed |
| US-20140371123-A1 | AQUEOUS OPHTHALMIC COMPOSITION | ROHTO PHARMA (JP) | 2014-12-18 | — | — | US | disclosed |
| US-20140350119-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ROHTO PHARMA (JP) | 2014-11-27 | — | — | US | disclosed |
| US-20140302146-A1 | Ophthalmic Aqueous Composition | ROHTO PHARMACEUTICAL CO.,LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| EP-2783689-A1 | KERATOCONJUNCTIVAL PROTECTING AGENT, OR KERATOCONJUNCTIVAL DISORDER INHIBITING AGENT | Toyo Sugar Refining Co., Ltd. (JP) | 2014-10-01 | — | — | EP | disclosed |
| US-20140243419-A1 | MUCOSALLY-APPLIED AGENT FOR PREVENTION, AMELIORATION OR TREATMENT OF RETINAL DISEASE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
| CN-103933198-A | Active mineral ion eye drops | SUI LIMEI | 2014-07-23 | — | — | CN | disclosed |
| EP-2730292-A1 | AQUEOUS OPHTHALMIC COMPOSITION | Rohto Pharmaceutical Co., Ltd. (JP) | 2014-05-14 | — | — | EP | disclosed |
| US-20140128475-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-05-08 | — | — | US | disclosed |
| EP-2219608-B1 | SELF SOLIDIFYING BIOERODIBLE BARRIER IMPLANT | TRILOGIC PHARMA LLC (US) | 2014-03-19 | — | — | EP | disclosed |
| US-8669241-B2 | Ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-03-11 | — | — | US | disclosed |
| US-20140045948-A1 | KIT OF OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-02-13 | — | — | US | disclosed |
| CN-103494828-A | Preparation method of sulfanilamide salt and trimethoprim soluble powder | RINGPU TIANJIN BIO TECHNOLOGY CO LTD | 2014-01-08 | — | — | CN | disclosed |
| US-20140005274-A1 | AQUEOUS OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-01-02 | — | — | US | disclosed |
| US-20140005277-A1 | AQUEOUS OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2014-01-02 | — | — | US | disclosed |
| US-20130338088-A1 | SELF SOLIDIFYING BIOERODIBLE BARRIER IMPLANT | TriLobic Pharma LLC (US) | 2013-12-19 | — | — | US | disclosed |
| US-20130331458-A1 | KIT OF OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-12-12 | — | — | US | disclosed |
| US-20130303626-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130303625-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130303627-A1 | OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130303624-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130296446-A1 | AQUEOUS OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-11-07 | — | — | US | disclosed |
| EP-2659911-A1 | AQUEOUS OPHTHALMIC COMPOSITION | Rohto Pharmaceutical Co., Ltd. (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20130281529-A1 | EYE DROP PREPARATION COMPRISING LATANOPROST | TEIKA PHARMACEUTICAL CO LTD (JP) | 2013-10-24 | — | — | US | disclosed |
| EP-2653155-A1 | OPHTHALMIC COMPOSITION FOR CONTACT LENS | Rohto Pharmaceutical Co., Ltd. (JP) | 2013-10-23 | — | — | EP | disclosed |
| US-20130274332-A1 | OPHTHALMIC COMPOSITION FOR CONTACT LENS | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-10-17 | — | — | US | disclosed |
| CN-103282052-A | Aqueous ophthalmic composition | ROHTO PHARMA | 2013-09-04 | — | — | CN | disclosed |
| CN-103269686-A | Ophthalmic composition for contact lens | ROHTO PHARMA | 2013-08-28 | — | — | CN | disclosed |
| US-8501230-B2 | Self solidifying bioerodible barrier implant | TRILOGIC PHARMA LLC (US) | 2013-08-06 | — | — | US | disclosed |
| US-8501822-B2 | Ophthalmic composition containing alginic acid or salt thereof | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| US-20130131166-A1 | BIOADHESIVE COMPOSITIONS FOR EPITHELIAL DRUG DELIVERY | TRILOGIC PHARMA LLC (US) | 2013-05-23 | — | — | US | disclosed |
| US-8435965-B2 | Composition for soft contact lens and adsorption suppressing method | LION CORPORATION (JP) | 2013-05-07 | — | — | US | disclosed |
| EP-2123278-B1 | EYE DROP PREPARATION COMPRISING LATANOPROST | TEIKA PHARMACEUTICAL CO LTD (JP) | 2013-01-09 | — | — | EP | disclosed |
| CN-101351199-B | Composition for soft contact lens and adsorption inhibition method | LION CORP | 2013-01-02 | — | — | CN | disclosed |
| US-20120238519-A1 | OPHTHALMIC COMPOSITION CONTAINING ALGINIC ACID OR SALT THEREOF | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2012-09-20 | — | — | US | disclosed |
| US-RE43583-E1 | Ophthalmic composition for soft contact lens comprising terpenoid | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2012-08-14 | — | — | US | disclosed |
| CN-101484177-B | Ophthalmic composition containing alginic acid or salt thereof | ROHTO PHARMACEUTICAL CO.,LTD. (JP) | 2011-12-28 | — | — | CN | disclosed |
| US-8067038-B2 | Ophthalmic composition for soft contact lens comprising terpenoid | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2011-11-29 | — | — | US | disclosed |
| CN-101658526-B | Veterinary compound enrofloxacin injection and preparation method thereof | JIANBO CHEN | 2010-12-29 | — | — | CN | disclosed |
| US-20100324110-A1 | Self Solidifying Bioerodible Barrier Implant | TRILOGIC PHARMA LLC (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100317615-A1 | Method of enhancing ocular penetration of a drug in an eyedrop | TORAY INDUSTRIES, INC. (JP) | 2010-12-16 | — | — | US | disclosed |
| CN-101313977-B | Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | LEI QINGLIAN | 2010-12-15 | — | — | CN | disclosed |
| CN-101313977-B | Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | LEI QINGLIAN | 2010-12-15 | — | — | CN | disclosed |
| US-20100297202-A1 | PLANAR ANTENNA AND METHOD OF MANUFACTURING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2010-11-25 | — | — | US | disclosed |
| EP-2241588-A1 | AQUEOUS DISPERSION CONTAINING POLYSACCHARIDE PARTICULATE GEL AND METHOD FOR PRODUCING THE SAME | Toray Industries, Inc. (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20100234318-A1 | OPHTHALMIC COMPOSITION CONTAINING ALGINIC ACID OR SALT THEREOF | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2219608-A1 | SELF SOLIDIFYING BIOERODIBLE BARRIER IMPLANT | Trilogic Pharma Llc (US) | 2010-08-25 | — | — | EP | disclosed |
| EP-2213308-A1 | Eyedrop comprising agar | TORAY INDUSTRIES INC. (JP) | 2010-08-04 | — | — | EP | disclosed |
| US-20100137252-A1 | Ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100120908-A1 | EYE DROP PREPARATION COMPRISING LATANOPROST | TEIKA PHARMACEUTICAL CO., LTD (JP) | 2010-05-13 | — | — | US | disclosed |
| US-20100069323-A1 | COMPOSITION FOR APPLICATION TO SKIN OR MUCOSA | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| CN-101658526-A | Veterinary compound enrofloxacin injection and preparation method thereof | JIANBO CHEN | 2010-03-03 | — | — | CN | disclosed |
| US-20100011989-A1 | OPHTHALMIC COMPOSITION FOR SOFT CONTACT LENS COMPRISING TERPENOID | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2123278-A1 | EYE DROP REPARATION COMPRISING LATANOPROST | Teika Pharmaceutical Co., Ltd. (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-7612115-B2 | Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| CN-101484177-A | Ophthalmic composition containing alginic acid or salt thereof | ROHTO PHARMA (JP) | 2009-07-15 | — | — | CN | disclosed |
| US-20090176737-A1 | Composition for Soft Contact Lens and Adsorption Suppressing Method | LION CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| WO-2009073658-A1 | SELF SOLIDIFYING BIOERODIBLE BARRIER IMPLANT | TRILOGIC PHARMA LLC (US) | 2009-06-11 | — | — | WO | disclosed |
| EP-2039370-A1 | OPHTHALMIC COMPOSITION FOR SOFT CONTACT LENS COMPRISING TERPENOID | Rohto Pharmaceutical Co., Ltd. (JP) | 2009-03-25 | — | — | EP | disclosed |
| CN-100467066-C | Polysaccharide-containing compositions and use thereof | TORAY IND SANTEN PHARMACEUTICA (JP) | 2009-03-11 | — | — | CN | disclosed |
| CN-100463668-C | Reversibly hot gelified water soluble medicine composition | PEIXUE LING (CN) | 2009-02-25 | — | — | CN | disclosed |
| CN-101351199-A | Composition for soft contact lens and adsorption inhibition method | LION CORP (JP) | 2009-01-21 | — | — | CN | disclosed |
| CN-101313977-A | Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | LEI QINGLIAN (CN) | 2008-12-03 | — | — | CN | disclosed |
| CN-101313977-A | Intestine toxicity syndrome vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | LEI QINGLIAN (CN) | 2008-12-03 | — | — | CN | disclosed |
| CN-101301292-A | Medicament composition for preventing and treating infectious serositis of duck | TIANJIN SHENGJI GROUP CO LTD (CN) | 2008-11-12 | — | — | CN | disclosed |
| CN-101301292-A | Medicament composition for preventing and treating infectious serositis of duck | TIANJIN SHENGJI GROUP CO LTD (CN) | 2008-11-12 | — | — | CN | disclosed |
| CN-100430069-C | Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof | PEIXUE LING (CN) | 2008-11-05 | — | — | CN | disclosed |
| EP-1967186-A1 | COMPOSITION FOR SOFT CONTACT LENS AND ADSORPTION SUPPRESSING METHOD | Lion Corporation (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-20080199524-A1 | Eyedrops containing particulate agar | TORAY INDUSTRIES, INC. (JP) | 2008-08-21 | — | — | US | disclosed |
| EP-1312366-B1 | GELLING AQUEOUS PHARMACEUTICAL COMPOSITIONS | WAKAMOTO PHARMA CO LTD (JP) | 2007-10-24 | — | — | EP | disclosed |
| CN-101011402-A | Compound sulfadimidine sodium injection and its preparation method | TIANJIN SHENGJI GROUP CO LTD (CN) | 2007-08-08 | — | — | CN | disclosed |
| US-20070166362-A1 | Transdermal and transmucosal preparations | KABUSHIKI KAISHA SANGI (JP) | 2007-07-19 | — | — | US | disclosed |
| EP-1797900-A1 | PREPARATION FOR PERCUTANEOUS/PERMUCOSAL ABSORPTION | KABUSHIKI KAISHA SANGI (JP) | 2007-06-20 | — | — | EP | disclosed |
| CN-1319597-C | Polysaccharide-containing compositions and use thereof | TORAY INDUSTRIES (JP) | 2007-06-06 | — | — | CN | disclosed |
| CN-1853727-A | Polysaccharide-containing compositions and use thereof | TORAY INDUSTRIES (JP) | 2006-11-01 | — | — | CN | disclosed |
| US-20060172969-A1 | Aqueous pharmaceutical compositions | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 2006-08-03 | — | — | US | disclosed |
| CN-1736474-A | Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof | LING PEIXUE (CN) | 2006-02-22 | — | — | CN | disclosed |
| US-20060035842-A1 | Ophthalmic composition | MENICON CO., LTD. (JP) | 2006-02-16 | — | — | US | disclosed |
| EP-1611883-A1 | COMPOSITION FOR OPHTHALMIC USE | MENICON CO., LTD. (JP) | 2006-01-04 | — | — | EP | disclosed |
| JP-2005343894-A | ANTIBACTERIAL INSTILLATION | ROHTO PHARMACEUT CO LTD | 2005-12-15 | — | — | JP | disclosed |
| CN-1706365-A | Reversibly hot gelified water soluble medicine composition | LING PEIXUE (CN) | 2005-12-14 | — | — | CN | disclosed |
| US-20040266725-A1 | Polysaccharide-containing compositions and use thereof | Toray Industries., Inc. (JP) | 2004-12-30 | — | — | US | disclosed |
| CN-1553816-A | Polysaccharide-containing compositions and use thereof | ������������ʽ���� | 2004-12-08 | — | — | CN | disclosed |
| US-20040228921-A1 | Compositions and methods for delivery of therapeutic agents | CHOWDHURY DIPAK K (US) | 2004-11-18 | — | — | US | disclosed |
| EP-1424081-A1 | POLYSACCHARIDE-CONTAINING COMPOSITIONS AND USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 2004-06-02 | — | — | EP | disclosed |
| US-20040087520-A1 | Compositions and methods for delivery of therapeutic agents | KENTUCKY SCIENCE AND TECHNOLOGY CORPORATION | 2004-05-06 | — | — | US | disclosed |
| US-20040034042-A1 | Preservative composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2004-02-19 | — | — | US | disclosed |
| US-20030194441-A1 | Aqueous pharmaceutical compositions | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 2003-10-16 | — | — | US | disclosed |
| EP-1312366-A1 | AQUEOUS PHARMACEUTICAL COMPOSITIONS | Wakamoto Pharmaceutical Co., Ltd. (JP) | 2003-05-21 | — | — | EP | disclosed |
| US-20030035846-A1 | Water having a superior ability to disperse oil and fats | HATTORI, TOSHIMITSU (JP) | 2003-02-20 | — | — | US | disclosed |
| JP-2000309526-A | ADHESIVE PLASTER FOR TREATING IMPETIGO | SEKISUI CHEM CO LTD | 2000-11-07 | — | — | JP | disclosed |
| EP-0694310-B1 | REVERSIBLE, THERMALLY GELLING WATER-BASE MEDICINAL COMPOSITION | WAKAMOTO PHARMA CO LTD (JP) | 2000-02-16 | — | — | EP | disclosed |
| CN-1048393-C | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 2000-01-19 | — | — | CN | disclosed |
| EP-0916621-A2 | Water having a superior ability to disperse oil and fats | Hattori, Toshimitsu (JP) | 1999-05-19 | — | — | EP | disclosed |
| JP-H10295777-A | STABLE ANTIBIOTIC OPHTHALMIC SOLUTION | TAISHO PHARMACEUT CO LTD | 1998-11-10 | — | — | JP | disclosed |
| US-5624962-A | FOR OPHTHALMIC, DERMATOLOGICAL AND BADY CAVITICAL USE | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1997-04-29 | — | — | US | disclosed |
| EP-0694310-A1 | REVERSIBLE, THERMALLY GELLING WATER-BASE MEDICINAL COMPOSITION | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1996-01-31 | — | — | EP | disclosed |
| EP-0452837-B1 | Adhesive device for transdermal administration of an active agent | NITTO DENKO CORP (JP) | 1995-08-16 | — | — | EP | disclosed |
| CN-1097593-A | Aqueous drug composition having property of reversible thermosetting gelation | WAKAMOTO PHARMA CO LTD (JP) | 1995-01-25 | — | — | CN | disclosed |
| EP-0521455-A2 | Aerosol composition containing a film-forming hydroxycarboxylic acid polymer | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-01-07 | — | — | EP | disclosed |
| US-5176916-A | Plaster layer containing a medicinal ingredient, hydrophobic polymer, absorption promoter, water and a hydrophilic polymer | NITTO ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1993-01-05 | — | — | US | disclosed |
| EP-0241050-B1 | AZACYCLOALKANE DERIVATIVES, ABSORPTION PROMOTERS CONTAINING THE DERIVATIVES AS THE EFFECTIVE INGREDIENT AND EXTERNAL PREPARATION CONTAINING THE ABSORPTION PROMOTERS | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1992-10-14 | — | — | EP | disclosed |
| EP-0227836-B1 | SUSTAINED RELEASING PATCH | TEIJIN LIMITED (JP) | 1991-12-27 | — | — | EP | disclosed |
| EP-0452837-A2 | Adhesive device for transdermal administration of an active agent | NITTO DENKO CORPORATION (JP) | 1991-10-23 | — | — | EP | disclosed |
| US-4882359-A | USED WITH DRUGS | HISAMITSU PHARMACEUTICAL CO., LTD. (JP) | 1989-11-21 | — | — | US | disclosed |
| US-4801458-A | POROUS HOLLOW FIBERS FILLED WITH MEDICINE | TEIJIN LIMITED (JP) | 1989-01-31 | — | — | US | disclosed |
| EP-0241050-A2 | Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparation containing the absorption promoters | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1987-10-14 | — | — | EP | disclosed |
| EP-0227836-A1 | SUSTAINED RELEASING PATCH | TEIJIN LIMITED (JP) | 1987-07-08 | — | — | EP | disclosed |
| EP-0055609-A1 | Composition for coelomic administration, its preparation, and ingredients for use therein | SHIONOGI & CO., LTD. (JP) | 1982-07-07 | — | — | EP | disclosed |
| EP-0055609-A1 | Composition for coelomic administration, its preparation, and ingredients for use therein | SHIONOGI & CO., LTD. (JP) | 1982-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (28 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128475-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ALDH1A2, ALDH1A3, PDE6D | ALDH1A1 155/4885ADRA1A 484/4885MAPT 3295/4885 |
| US-20060035842-A1 | Ophthalmic composition | UACA, CRYZ, CRYAA | ALDH1A1 4318/4885ADRA1A 3420/4885MAPT 232/4885 |
| US-20160367584-A1 | PROTECTIVE AGENT FOR KERATOCONJUNCTIVA OR SUPPRESSIVE AGENT FOR KERATOCONJUNCTIVAL DISORDER | UGCG, GBA1, GOLGA2 | ALDH1A1 1942/4885ADRA1A 2459/4885MAPT 4706/4885 |
| US-20160368885-A1 | MALEATE OF ANTI-PRION COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION THEREOF | PRNP, MAPT, PSEN1 | ALDH1A1 1722/4885ADRA1A 3061/4885MAPT 2/4885 |
| US-20140302146-A1 | Ophthalmic Aqueous Composition | CRYZ, NONO, PDE6C | ALDH1A1 3615/4885ADRA1A 433/4885MAPT 1966/4885 |
| US-20140243419-A1 | MUCOSALLY-APPLIED AGENT FOR PREVENTION, AMELIORATION OR TREATMENT OF RETINAL DISEASE | ALDH1A2, AGER, GLA | ALDH1A1 522/4885ADRA1A 973/4885MAPT 3383/4885 |
| US-20210315807-A1 | HYDROGEL COMPOSITION AND HYDROGEL LENS | CRYAA, CRYZ, CRYAB | ALDH1A1 3739/4885ADRA1A 3920/4885MAPT 245/4885 |
| US-20130131166-A1 | BIOADHESIVE COMPOSITIONS FOR EPITHELIAL DRUG DELIVERY | OPRK1, EPCAM, OPRL1 | ALDH1A1 715/4885ADRA1A 431/4885MAPT 2867/4885 |
| US-20130338088-A1 | SELF SOLIDIFYING BIOERODIBLE BARRIER IMPLANT | CUTA, SP1, EPCAM | ALDH1A1 678/4885ADRA1A 2103/4885MAPT 4541/4885 |
| US-20040034042-A1 | Preservative composition | XDH, XPA, SORBS1 | ALDH1A1 714/4885ADRA1A 2775/4885MAPT 412/4885 |
| US-12005070-B2 | Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder | UGCG, GBA1, GOLGA2 | ALDH1A1 1942/4885ADRA1A 2459/4885MAPT 4706/4885 |
| US-20100317615-A1 | Method of enhancing ocular penetration of a drug in an eyedrop | PDE6G, PDE6A, PDE6D | ALDH1A1 3227/4885ADRA1A 2033/4885MAPT 1863/4885 |
| US-20150025154-A1 | OPHTHALMIC COMPOSITION | GSTO1, GSTK1, GSTA1 | ALDH1A1 342/4885ADRA1A 207/4885MAPT 2645/4885 |
| US-20130331458-A1 | KIT OF OPHTHALMIC COMPOSITION | KIT, F7, GGPS1 | ALDH1A1 1296/4885ADRA1A 2599/4885MAPT 3486/4885 |
| US-20140045948-A1 | KIT OF OPHTHALMIC COMPOSITION | KIT, F7, GGPS1 | ALDH1A1 1296/4885ADRA1A 2599/4885MAPT 3486/4885 |
| US-10039709-B2 | Bioadhesive compositions for epithelial drug delivery | OPRK1, EPCAM, OPRL1 | ALDH1A1 715/4885ADRA1A 431/4885MAPT 2867/4885 |
| US-20160089345-A1 | KIT OF OPHTHALMIC COMPOSITION | KIT, F7, GGPS1 | ALDH1A1 1296/4885ADRA1A 2599/4885MAPT 3486/4885 |
| US-20130303627-A1 | OPHTHALMIC COMPOSITION | GSTO1, GSTK1, GSTA1 | ALDH1A1 342/4885ADRA1A 207/4885MAPT 2645/4885 |
| US-20080199524-A1 | Eyedrops containing particulate agar | PDE6G, PDE6A, PDE7A | ALDH1A1 1262/4885ADRA1A 2969/4885MAPT 155/4885 |
| US-20220168434-A1 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | TTR, ALB, CRYAB | ALDH1A1 1630/4885ADRA1A 1136/4885MAPT 1175/4885 |
| US-20040266725-A1 | Polysaccharide-containing compositions and use thereof | PDE6G, PDE6A, CUTA | ALDH1A1 1983/4885ADRA1A 3936/4885MAPT 245/4885 |
| US-20130303625-A1 | AGENT FOR THE PREVENTION, IMPROVEMENT OR TREATMENT OF RETINAL DISEASE | ALDH1A2, ALDH1A3, PDE6D | ALDH1A1 155/4885ADRA1A 484/4885MAPT 3295/4885 |
| US-20160136275-A1 | OPHTHALMIC COMPOSITION | PLPBP, CRYAA, CRYAB | ALDH1A1 2964/4885ADRA1A 2039/4885MAPT 349/4885 |
| US-20100324110-A1 | Self Solidifying Bioerodible Barrier Implant | CUTA, SP1, EPCAM | ALDH1A1 709/4885ADRA1A 2448/4885MAPT 4465/4885 |
| US-20130303624-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ALDH1A2, PDE6C, PTGER3 | ALDH1A1 137/4885ADRA1A 237/4885MAPT 1500/4885 |
| US-20150064281-A1 | OPHTHALMIC COMPOSITION | TUBB2B, TUBB, TUBA1B | ALDH1A1 227/4885ADRA1A 3057/4885MAPT 2977/4885 |
| US-20130303626-A1 | OPHTHALMIC COMPOSITION | PLPBP, CRYAA, CRYAB | ALDH1A1 2964/4885ADRA1A 2039/4885MAPT 349/4885 |
| US-20140350119-A1 | OPHTHALMIC COMPOSITION COMPRISING GERANYLGERANYLACETONE | ALDH1A2, PDE6C, PTGER3 | ALDH1A1 137/4885ADRA1A 237/4885MAPT 1500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.